CUSIP 375558103COMGILDQ4 2025
108 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jun 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | M · Option Exercise | 589 | $0.00 | $0 | 5.6K | SEC |
| 2 | Jun 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | F · Tax | 283 | $121.48 | $34.4K | 5.4K | SEC |
| 3 | Jun 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | M · Option Exercise | 589 |
See the full Form 4 transaction history for Gilead Sciences Inc.
Unlock all transactions| $0.00 |
| $0 |
| 20.0K |
| SEC |
| 4 | Jun 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | M · Option Exercise | 2.8K | $0.00 | $0 | 128.6K | SEC |
| 5 | Jun 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | F · Tax | 1.3K | $121.48 | $162.9K | 127.2K | SEC |
| 6 | Jun 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | M · Option Exercise | 2.8K | $0.00 | $0 | 27.9K | SEC |
| 7 | Jun 10, 2026 | Berger Dietmar | Chief Medical Officer | M · Option Exercise | 533 | $0.00 | $0 | 19.5K | SEC |
| 8 | Jun 10, 2026 | Berger Dietmar | Chief Medical Officer | F · Tax | 263 | $121.48 | $31.9K | 19.3K | SEC |
| 9 | Jun 10, 2026 | Berger Dietmar | Chief Medical Officer | M · Option Exercise | 533 | $0.00 | $0 | 46.9K | SEC |
| 10 | Jun 10, 2026 | O'Day Daniel Patrick | Chairman & CEO | M · Option Exercise | 8.8K | $0.00 | $0 | 626.3K | SEC |